XT-203: A NOVEL PAIN AND SUBSTANCE ABUSE THERAPEUTIC

$1,412,161FY2018Defense Health AgencyDOD

Xalud Therapeutics, Inc

Investigators

View source on USAspending →

XT-203: A NOVEL PAIN AND SUBSTANCE ABUSE THERAPEUTIC · GrantIndex